Early outcomes of transcatheter tricuspid valve-in-valve implantation: a case series

Imagem de Miniatura
Arquivos
art_VIOTTO_Early_outcomes_of_transcatheter_tricuspid_valveinvalve_implantation_a_2019.PDF (354.72 KB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS
Autores
Citação
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, v.29, n.1, p.59-63, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: In this study, we sought to evaluate early outcomes of transcatheter valve-in-valve implantation in patients with a degenerated bioprosthesis in the tricuspid position. METHODS: We used a prospective study, which included patients with a degenerated bioprosthesis in the tricuspid position who were considered high-risk by our heart team and who underwent a valve-in-valve implantation. The procedures were performed via transjugular venous access and were done with the patient under general anaesthesia with transoesophageal echocardiographic and fluoroscopic guidance. Perioperative data were analysed, and the patients were followed prospectively. RESULTS: Seven patients were included. The baseline diagnoses were 3 patients with Ebstein's anomaly, 1 patient with tetralogy of Fallot, 1 patient with neonatal endocarditis, 1 patient with ventricular septal defect with a double tricuspid lesion and 1 patient with rheumatic mitral and tricuspid valve who underwent a combined transapical mitral and transjugular tricuspid valve-in-valve implantation. age was 33 +/- 10.8 years and 57.1% of the patients were men. The mean number of previous thoracotomies was 3 +/- 2 (range 1-5) procedures. The mean follow-up was 1.24 years. The implant was successful in all cases, and there was no need for conversion to open surgery. There were no deaths during the study period, and all patients are currently in the New York Heart Association functional class I/II. There was a statistically significant difference when the mean transvalvular gradients preimplantation and postimplantation were compared (P < 0.001). CONCLUSIONS: Percutaneous tricuspid valve implantation should be considered a safe and effective therapy and stands as a viable, reliable alternative for the treatment of a degenerated bioprosthesis in high-surgical-risk/inoperable patients.
Palavras-chave
Tricuspid valve, Tricuspid regurgitation, Transcatheter, Bioprosthesis degeneration
URI
https://observatorio.fm.usp.br/handle/OPI/34357
Referências
  1. Alvarez-Fuente M, 2017, CARDIOL YOUNG, V27, P1633, DOI 10.1017/S1047951117000786
  2. Antunes MJ, 2017, EUR J CARDIO-THORAC, V52, P1022, DOI 10.1093/ejcts/ezx279
  3. Asmarats L, 2018, INTERACT CARDIOV TH, V26, P527, DOI 10.1093/icvts/ivx345
  4. Cahill TJ, 2018, EUR HEART J, V39, P2625, DOI 10.1093/eurheartj/ehy244
  5. Cerillo AG, 2012, EUR J CARDIO-THORAC, V42, P1056, DOI 10.1093/ejcts/ezs446
  6. Cheung A, 2012, J CARDIAC SURG, V27, P196, DOI 10.1111/j.1540-8191.2011.01401.x
  7. De Brabandere K, 2016, EUR J CARDIO-THORAC, V49, P1737, DOI 10.1093/ejcts/ezv350
  8. Fernandez-Lopez L, 2018, REV ESP CARDIOL, V71, P1070, DOI 10.1016/j.rec.2017.11.018
  9. Gaia DF, 2012, EUR J CARDIO-THORAC, V41, P696, DOI 10.1093/ejcts/ezr038
  10. Godart F, 2014, ARCH CARDIOVASC DIS, V107, P583, DOI 10.1016/j.acvd.2014.07.051
  11. Greif M, 2013, CAN J CARDIOL, V29, DOI 10.1016/j.cjca.2012.11.027
  12. Iino K, 2011, EUR J CARDIO-THORAC, V40, P503, DOI 10.1016/j.ejcts.2010.11.051
  13. Lausberg HF, 2017, EUR J CARDIO-THORAC, V52, P189, DOI 10.1093/ejcts/ezx084
  14. Loyalka P, 2017, TEX HEART I J, V44, P209, DOI 10.14503/THIJ-15-5639
  15. McElhinney DB, 2016, CIRCULATION, V133, P1582, DOI 10.1161/CIRCULATIONAHA.115.019353
  16. Praz F, 2015, JACC-CARDIOVASC INTE, V8, P1777, DOI 10.1016/j.jcin.2015.08.015
  17. Reddy YNV, 2015, WORLD J PEDIATR CONG, V6, P667, DOI 10.1177/2150135115586270
  18. Ribichini F, 2013, AM J CARDIOL, V112, P1051, DOI 10.1016/j.amjcard.2013.05.043
  19. Ruparelia N, 2016, CATHETER CARDIO INTE, V88, P994, DOI 10.1002/ccd.26584
  20. Sawaya Fadi J, 2017, Interv Cardiol, V12, P126, DOI 10.15420/icr.2016:29:2
  21. Scarsini R, 2017, INT J CARDIOL, V235, P141, DOI 10.1016/j.ijcard.2017.02.076
  22. Sung K, 2009, EUR J CARDIO-THORAC, V36, P825, DOI 10.1016/j.ejcts.2009.04.063
  23. Taramasso Maurizio, 2017, Interv Cardiol, V12, P51, DOI 10.15420/icr.2017:3:2
  24. Vahanian A, 2018, EUROINTERVENTION, V13, P1631, DOI 10.4244/EIJV13I14A264
  25. van Slooten YJ, 2014, EUR J CARDIO-THORAC, V45, P83, DOI 10.1093/ejcts/ezt259

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - ODS/03